Nora Volkow, who was involved with the study and is director of the National Institute on Drug Abuse, told the New York Times more studies are absolutely needed to investigate any cause and effect involved
Experience fast-acting results with our local healthcare team
The 2025 trials asked something harder: whether the drugs already on the market, at the doses and in the populations studied, can slow human neurodegeneration, and for semaglutide in Alzheimers disease and exenatide in Parkinsons disease, the answer was no
As a topical treatment, systemic exposure is minimal
Labeling and characterization of human GLP-1-secreting L-cells in primary ileal organoid culture
It was also found to reduce testosterone, lipid and insulin levels, give weight loss and improved fertility